Subjects: 3 selected - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Economics, Pharmaceutical ✖ Subjects Humans ✖ Subjects Patents as Topic ✖

1. Biologics in perspective: the case for generic biologic drugs

Publication:: Washington, D.C. : AARP Public Policy Institute, c2009
Subject(s):: Biological Products -- economics
Drug Approval
Drugs, Generic -- economics
Chemistry, Pharmaceutical -- economics
Drug Costs
Economics, Pharmaceutical
Health Expenditures
Patents as Topic
Humans
United States

2. The effect of Medicare Part D on evergreening, generic entry, and drug prices

Author(s):: Sanzenbacher, Geoffrey T., author
Wettstein, Gal, author
Publication:: Chestnut Hill, MA : Center for Retirement Research at Boston College, May 2019
Subject(s):: Drug Costs
Drugs, Generic -- economics
Medicare Part D -- economics
Patents as Topic
Aged
Drug Industry -- economics
Economics, Pharmaceutical
Humans
United States
United States. Food and Drug Administration.
Medical Expenditure Panel Survey (U.S.)

3. Cost savings

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):: Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
Access to Information
Biosimilar Pharmaceuticals
Commerce
Conflict of Interest
Drug Industry
Insurance, Pharmaceutical Services
Managed Care Programs
Medicaid -- economics
Medicare Part D -- economics
Patents as Topic
State Government
Humans
United States